B

Bioatla Inc
NASDAQ:BCAB

Watchlist Manager
Bioatla Inc
NASDAQ:BCAB
Watchlist
Price: 1.71 USD -14.07%
Market Cap: 82.7m USD
Have any thoughts about
Bioatla Inc?
Write Note

Bioatla Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bioatla Inc
Retained Earnings Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioatla Inc
NASDAQ:BCAB
Retained Earnings
-$416.3m
CAGR 3-Years
-66%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$25.5B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-18%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$30.8B
CAGR 3-Years
22%
CAGR 5-Years
36%
CAGR 10-Years
71%

See Also

What is Bioatla Inc's Retained Earnings?
Retained Earnings
-416.3m USD

Based on the financial report for Dec 31, 2023, Bioatla Inc's Retained Earnings amounts to -416.3m USD.

What is Bioatla Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-29%

Over the last year, the Retained Earnings growth was -42%. The average annual Retained Earnings growth rates for Bioatla Inc have been -66% over the past three years , -29% over the past five years .

Back to Top